Evidence map›Paper›PMID 35146520›Full record

ArticleJournal of radiation research2022

Pattern of chromosomal aberrations persisting over 30 years in a Chernobyl Nuclear Power Plant accident survivor: study using mFISH.

Victoriya Nikitina, Vladimir Nugis, Tatiyana Astrelina, Diana Zheglo, Irina Kobzeva, Mariya Kozlova, Irina Galstyan, Elena Lomonosova, Aliy Zhanataev, Tatiyana Karaseva and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of radiation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Preleukemic Fusion Genes Induced via Ionizing Radiation.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Victoriya NikitinaState Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biology Agency of Russia, 123128 Zhivopisnaya str., 46, Moscow, Russia.
Vladimir NugisState Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biology Agency of Russia, 123128 Zhivopisnaya str., 46, Moscow, Russia.
Tatiyana AstrelinaState Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biology Agency of Russia, 123128 Zhivopisnaya str., 46, Moscow, Russia.
Diana ZhegloFederal State Budgetary Scientific Institution "Research Centre for Medical Genetics", 115522, Moskvorechye str., 1, Moscow, Russia.
Irina KobzevaState Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biology Agency of Russia, 123128 Zhivopisnaya str., 46, Moscow, Russia.
Mariya KozlovaState Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biology Agency of Russia, 123128 Zhivopisnaya str., 46, Moscow, Russia.
Irina GalstyanState Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biology Agency of Russia, 123128 Zhivopisnaya str., 46, Moscow, Russia.
Elena LomonosovaState Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biology Agency of Russia, 123128 Zhivopisnaya str., 46, Moscow, Russia.
Aliy ZhanataevResearch Zakusov Institute of Pharmacology, 125315 Baltyiskaya str., 8, Moscow, Russia.
Tatiyana KarasevaState Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biology Agency of Russia, 123128 Zhivopisnaya str., 46, Moscow, Russia.
Alexander S SamoylovState Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biology Agency of Russia, 123128 Zhivopisnaya str., 46, Moscow, Russia.
Institute of Pharmacology Russian Academy of Medical Sciences · RUResearch Centre for Medical Genetics · RU

Funding

Burnazyan Medical Biophysical Center
6 · The paper itself

Abstract

The long-term in vivo cytogenetic effects of high-dose radiation exposure can be traced in accidentally irradiated persons, and particularly useful for developing strategies of monitoring and therapy of such patients, as well as for elucidating the fundamental aspects of hematopoiesis and radiobiology. Using 24-color fluorescent in situ hybridization (mFISH), we analysed the frequency and the spectrum of chromosomal aberrations (CA) in peripheral blood lymphocytes of the Chernobyl Nuclear Power Plant (NPP) accident victim 30, 31, 32 and 33 years after acute accidental exposure to high-dose gamma radiation of the whole body. Totally, 993 metaphase cells were analyzed (or 219, 272, 258, 244 cells each year), of which 297 were aberrant. Our study demonstrated a constant aberrant cell frequency at 28% in 2016-2018 years, while in 2019, a significant increase up to 35% occurred due to contribution of significantly elevated frequency of simple aberrations in the absence of evident recent genotoxic factors. Four clonal aberrations were detected, three of which persisted for more than one year at a frequency up to 2.5% of analyzed cells. The distribution of 731 breakpoints per individual chromosomes was nearly proportional to their physical length, excepting Chromosomes 13 and 20, which were significantly breakpoint-deficient compared to the genome median rate. Monitoring of the long-term effects on chromosomal instability caused by radiation exposure is important for understanding and predicting the long-term effects of ionizing radiation.

Indexed as

Chernobyl Nuclear AccidentChromosome AberrationsHumansIn Situ Hybridization, FluorescenceLymphocytesNuclear Power PlantsSurvivorsChernobyl Nuclear Power Plant (NPP) accidentchromosomal aberrations (CA)exposuremFISH

Identifiers

PMID35146520
PMCPMC8944318
OpenAlexW4206113866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.